Numan Y, Abdel Rahman Z, Grenet J, Boisclair S, et al. Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors. Am J Hematol 2022 Jan 3. doi: 10.1002/ajh.26447.
PMID: 34981560